title: Development of novel bioanalytical methods to determine the effective concentrations of phosphorodiamidate morpholino oligomers in tissues and cells.
abstract: Phosphorodiamidate morpholino oligomers (PMO) are neutrally charged, sequence-specific antisense agents that interfere with targeted gene expression. PMO have been shown to be highly specific and potent therapies after cellular uptake, yet methods to detect PMO in tissue and inside the cell are limited. We offer in this report novel methods for the detection of cellular resident PMO using flow cytometry-fluorescence in situ hybridization (flow FISH) and a sandwich hybridization technique to quickly and sensitively quantify tissue resident PMO. These methods rely on oligonucleotide probes complementary to a PMO to specifically detect and quantify cell-associated and tissue resident PMO after in vitro or in vivo administration. Using the sandwich hybridization technique, we show that intranasally delivered PMO demonstrates zero-order clearance kinetics from the lung. Furthermore, PMO was detected in nonhematopoietic and hematopoietic cells of the lung regardless of influenza virus infection, although an increase in PMO uptake in infected hematopoietic cells was observed. Coincident measurement of target knock-down to cell-associated influenza A PMO concentration allowed for the calculation of an EC50.
authors.affiliation: Discovery Unit, Sarepta Therapeutics, Corvallis, Oregon.
authors.forename: Frederick J
authors.initials: FJ
authors.lastname: Schnell
authors.forename: Stacy L
authors.initials: SL
authors.lastname: Crumley
authors.forename: Dan V
authors.initials: DV
authors.lastname: Mourich
authors.forename: Patrick L
authors.initials: PL
authors.lastname: Iversen
keywords: drug discovery; gene regulation; nucleic acids; virology